Receptor, Angiotensin, Type 1
"Receptor, Angiotensin, Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An angiotensin receptor subtype that is expressed at high levels in a variety of adult tissues including the CARDIOVASCULAR SYSTEM, the KIDNEY, the ENDOCRINE SYSTEM and the NERVOUS SYSTEM. Activation of the type 1 angiotensin receptor causes VASOCONSTRICTION and sodium retention.
| Descriptor ID |
D044140
|
| MeSH Number(s) |
D12.776.543.750.695.047.625 D12.776.543.750.750.130.750
|
| Concept/Terms |
Receptor, Angiotensin, Type 1- Receptor, Angiotensin, Type 1
- Angiotensin II Type 1 Receptor
- Angiotensin AT1 Receptor
- AT1 Receptor, Angiotensin
- Receptor, Angiotensin AT1
- Angiotensin Type 1 Receptor
- Receptor, Angiotensin II Type 1
Receptor, Angiotensin, Type 1b- Receptor, Angiotensin, Type 1b
- Angiotensin II Type 1b Receptor
- Angiotensin Type 1b Receptor
- Angiotensin AT1b Receptor
- AT1b Receptor, Angiotensin
- Receptor, Angiotensin AT1b
- Receptor, Angiotensin II Type 1b
Receptor, Angiotensin, Type 1a- Receptor, Angiotensin, Type 1a
- Angiotensin II Type 1a Receptor
- Angiotensin AT1a Receptor
- AT1a Receptor, Angiotensin
- Receptor, Angiotensin AT1a
- Angiotensin Type 1a Receptor
- Receptor, Angiotensin II Type 1a
|
Below are MeSH descriptors whose meaning is more general than "Receptor, Angiotensin, Type 1".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Angiotensin [D12.776.543.750.695.047]
- Receptor, Angiotensin, Type 1 [D12.776.543.750.695.047.625]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Angiotensin [D12.776.543.750.750.130]
- Receptor, Angiotensin, Type 1 [D12.776.543.750.750.130.750]
Below are MeSH descriptors whose meaning is more specific than "Receptor, Angiotensin, Type 1".
This graph shows the total number of publications written about "Receptor, Angiotensin, Type 1" by people in this website by year, and whether "Receptor, Angiotensin, Type 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 2 | 3 |
| 2015 | 2 | 2 | 4 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptor, Angiotensin, Type 1" by people in Profiles.
-
Marcum ZA, Cohen JB, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Williamson J, Pajewski NM, Bress AP. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. JAMA Netw Open. 2022 01 04; 5(1):e2145319.
-
Singh A, Mohanty I, Singh J, Rattan S. BDNF augments rat internal anal sphincter smooth muscle tone via RhoA/ROCK signaling and nonadrenergic noncholinergic relaxation via increased NO release. Am J Physiol Gastrointest Liver Physiol. 2020 01 01; 318(1):G23-G33.
-
Mohanty I, Singh J, Rattan S. Downregulation of thromboxane A2 and angiotensin II type 1 receptors associated with aging-related decrease in internal anal sphincter tone. Sci Rep. 2019 05 01; 9(1):6759.
-
Owens EA, Jie L, Reyes BAS, Van Bockstaele EJ, Osei-Owusu P. Elastin insufficiency causes hypertension, structural?defects and abnormal remodeling?of?renal vascular signaling. Kidney Int. 2017 11; 92(5):1100-1118.
-
Katz MG, Brandon-Warner E, Fargnoli AS, Williams RD, Kendle AP, Hajjar RJ, Schrum LW, Bridges CR. Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression. J Thorac Cardiovasc Surg. 2016 Apr; 151(4):1191-200.e3.
-
Yang J, Li L, Shang JY, Cai L, Song L, Zhang SL, Li H, Li X, Lau WB, Ma XL, Liu HR. Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia. J Hypertens. 2015 May; 33(5):1046-56.
-
Rinc?n J, Correia D, Arcaya JL, Finol E, Fern?ndez A, P?rez M, Yaguas K, Talavera E, Ch?vez M, Summer R, Romero F. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. Life Sci. 2015 Mar 01; 124:81-90.
-
Makadia HK, Anderson WD, Fey D, Sauter T, Schwaber JS, Vadigepalli R. Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology. Biophys J. 2015 Jan 06; 108(1):211-23.
-
Park J, Ogunnaike B, Schwaber J, Vadigepalli R. Identifying functional gene regulatory network phenotypes underlying single cell transcriptional variability. Prog Biophys Mol Biol. 2015 Jan; 117(1):87-98.
-
Yang X, Wang F, Lau WB, Zhang S, Zhang S, Liu H, Ma XL. Autoantibodies isolated from preeclamptic patients induce endothelial dysfunction via interaction with the angiotensin II AT1 receptor. Cardiovasc Toxicol. 2014 Mar; 14(1):21-9.